Our results showed that icariin treatment significantly reduced the level of Drp1 and increased the level of Mfn2 in AD neurons, which may be partially attributed to its inhibitory effect on the aberrant distribution of Aβ in AD neurons. Here, DNM1L is linked to Alzheimer disease.